Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Arrayit quotes $7.1 million variation identification platform (VIP) genotyping package to top clinical testing laboratory in Southeast Asia
Buyer Beware,A list of Arrayit Corporation patents:
https://t.co/EMXlE743rz
Steady gains, churning the .005's.is gone..... welcome to the board my friend:)
Arrayit reports $6MM business development proposal from tissue microarray technology leader Unitma Seoul South Korea unitma.com
Yes General my friend, Chapter 7 liquidation at .0058--
YA ..0057 BID ASK .0058
You worng
Huge!!
NEW...Arrayit reports $6MM business development proposal from tissue microarray technology leader Unitma Seoul South Korea www.unitma.com
Huge!!
NEW...Arrayit reports $6MM business development proposal from tissue microarray technology leader Unitma Seoul South Korea www.unitma.com
Wow, Wow another good one Arrayit reports microarray technology sale to $170.2 billion pharma giant Merck Sharp & Dohme NYSE:MRK Rahway NJ http://www.merck.com/index.html
WOW, WOW Arrayit schedules strategic partnering meeting with $258.7 billion global life sciences leader GE Healthcare NYSE:GE http://www.gelifesciences.com
bgrass,Live and learn !!! we going up tomorrow ---cover the shorts
There is absolutely no other company, none, none whatsoever, that come anywhere close to being as severely undervalued as Arrayit. Anybody that wants to prove us different, go ahead. Provide us a link, show us another company that is making the revenue that ARYC is, has the location right in the middle of Silicon Valley, has the products, has the patents, has the innovation that Arrayit has. There is none. None. Show us otherwise.....waiting....
Arrayit and USDA Expanding Patent Protection for Food Safety Testing Worldwide
SOURCE: Arrayit Corporation
SUNNYVALE, CA / ACCESSWIRE / May 7, 2015 / The ongoing Cooperative Research and Development Agreement (CRADA) between Arrayit Corporation (OTCQB: ARYC) and the United States Department of Agriculture’s Agricultural Research Service (USDA-ARS), "Rapid and Cost Effective Detection Technologies for Noroviruses and Other Foodborne Pathogens," entitles Arrayit to negotiate for an exclusive license to commercialize the technology.
Much of the food consumed in the United States, including 50% of the produce the U.S. consumers use during the winter months, is grown outside of the country. Arrayit and USDA-ARS are developing food safety technologies that can be applied to various foods, wherever they are grown to include key food-producing nations such as Brazil, Canada, China, various European countries, Mexico and Peru.
Arrayit and the USDA-ARS have entered into a CRADA to develop a rapid, portable, cost-effective and high-throughput detection system for surveillance of multiple bacterial and viral foodborne pathogens including Campylobacter, E. coli, hepatitis, Listeria, norovirus and Salmonella.
About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. Please visit www.arrayit.com for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-K for the fiscal year ended December 31, 2014.
Yup ARYC is a real rocket ship!!
No 'lucky,mydog you can not provide any link
I Will join with you soon. holding
we going green today.
wrong !!!!!
The ask is .0057
Agree
Almost $1.2 million in sales in the past 5 weeks :)= $15M A YEAR
$ARYC is a Silicon Valley company that is currently trading under a penny per share but not for much longer:
Follow @Arrayit on Twitter
www.arrayit.com
Wow another GREAT week of trading is about to commence for this sub penny called ARYC!!! The best is yet to come.
Fantastic week coming for ARYC !!!
The train leaving the station Buy now or you will regret later
Agree. ARYC is 100% Undervalued Stocks . Buy now or you regret later
ARYC ....... Arrayit Corporation is an emerging Biotechnology company in the heart of Silicon Valley.
Arrayit signs $27.1 million term sheet for microarray services with US-based research leader
http://
arrayit.com/Services/servi
ces.html
Maybe this is the week ---Go PMBS
The company is open to shareholders visiting:
927 Thompson Place
Sunnyvale, CA 94085
USA
ARYC is number 1 on Breakout board!!
SKULL AND CROSSBONES FOR ARYC. --- All will change very soon I promise
The company is open to shareholders visiting:
927 Thompson Place
Sunnyvale, CA 94085
USA
15 patents! How many I OTC companies have 15 patents?
This is NOT a P&D company. There's no evidence of that whatsoever. Buying shares sub-penny currently and holding will create immense wealth. There is no reason that it should not be trading over $1 per share. There are no promotions, no paid pumping, ARYC is a real company that is working its way back to the Nasdaq.
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
THIS WARNING does not have any base here. sorry my friend.
I expect to see the filings either sometime next week or the 15th day. . So keep your eyes on OTCMARKETS.
I promise is there go all over the tweets over 3 months
Number 1 number 1 all the way ---BOOM